Idiopathic Inflammatory Myositis Market The idiopathic inflammatory myositis treatment market is poised for significant expansion, driven by the introduction of innovative targeted therapies and increasing disease awareness. Key idiopathic inflammatory myositis companies, including Octapharma, Pfizer, Mitsubishi Tanabe Pharma, AstraZeneca, Priovant Therapeutics, and CSL, among others, are advancing the treatment landscape with promising therapies, addressing the […]
